Engineers and oncologists teamed to develop a microfluidic chip capable of capturing the body’s natural killer immune cells to harvest their cancer-killing exosomes.

Facing a challenging diagnosis of metastatic urologic cancer, one of the state’s top communications professionals leans into her job, laughter and love.

A new understanding of intracellular pathways activated as T cells start to mount an immune response offers clues against graft-versus-host disease, a serious complication of bone marrow transplantation.

A combination approach, which included metabolic reprogramming and immunotherapy, led to complete tumor regression in 60% of study mice.

Throughout the pandemic, researchers have continued to push the boundaries of cancer prevention, diagnosis and treatment.

Estrogen-lowering aromatase inhibitors are frequently prescribed to women with ovarian and uterine cancers. New research sheds light on how side effects impact these patients.

Increasingly, scientists like those at the Rogel Cancer Center are using 3-D cell cultures to more closely model cancer cells in the body.

The analysis highlights the diversity of immune response in pancreatic cancer, and points toward the need for treatments tailored to individual patients.

The U-M-led development and validation of a staging system for non-metastatic prostate cancer could help doctors and patients assess treatment options, as well as improve clinical trials. 

Researchers have demonstrated that a new liquid biopsy approach overcomes traditional barriers to quickly and efficiently diagnose and monitor high-grade gliomas.

This phase 2 trial also identified a subset of patients with specific mutations who may see the most benefit from the drug.

A U-M Rogel Cancer study provides an updated, more comprehensive look at trends for this rare, aggressive form of breast cancer over the last four decades.

The new approach could help doctors to separate aggressive stage 0 breast cancer from non-aggressive forms, sparing some women unnecessary mastectomies.

Though they often receive little fanfare, postdocs are critical to the success of the Rogel Cancer Center’s research programs.

A roundup of several recent Michigan Medicine discoveries that are shedding new light on pediatric brain cancers and helping to improve treatment options.